Nurix Therapeutics (NRIX) Stock Chart & Stock Price History $12.15 -0.40 (-3.19%) Closing price 04:00 PM EasternExtended Trading$12.14 -0.01 (-0.04%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nurix Therapeutics Stock Price Performance 5 Day Performance-6.47%1 Month Performance-21.36%3 Month Performance-36.42%6 Month Performance-47.29%Year-To-Date Performance-35.51%1 Year Performance-17.35% Receive NRIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address NRIX Stock Chart for Friday, March, 28, 2025 NRIX Chart by TradingViewRemove Ads Nurix Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025$12.55$12.15-3.19%$12.72$12.00623,319 shs$922.03 million03/27/2025$12.73$12.55-1.41%$13.10$12.39577,846 shs$952.38 million03/26/2025$12.58$12.73+1.19%$12.78$12.20830,548 shs$966.04 million03/25/2025$13.34$12.58-5.70%$13.54$12.54847,242 shs$954.66 million03/24/2025$12.99$13.34+2.69%$13.57$13.03976,097 shs$1.01 billion03/21/2025$13.87$12.99-6.34%$13.67$12.752.29 million shs$985.77 million03/20/2025$13.90$13.87-0.22%$14.59$13.681.50 million shs$1.05 billion03/19/2025$13.66$13.90+1.76%$14.06$13.56681,299 shs$1.05 billion03/18/2025$13.93$13.66-1.94%$13.86$13.51655,763 shs$1.04 billion03/17/2025$13.59$13.93+2.50%$13.96$13.04757,443 shs$1.06 billion Get the Latest News and Ratings for NRIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025$13.19$13.59+3.03%$13.64$13.12680,828 shs$1.03 billion03/13/2025$14.54$13.19-9.28%$14.67$12.981.89 million shs$1.00 billion03/12/2025$13.90$14.54+4.60%$14.87$14.071.18 million shs$1.10 billion03/11/2025$13.59$13.90+2.28%$13.97$13.30594,261 shs$1.05 billion03/10/2025$13.86$13.59-1.95%$14.16$13.33584,960 shs$1.03 billion03/07/2025$14.05$13.86-1.35%$14.29$13.71576,560 shs$1.05 billion03/06/2025$14.27$14.05-1.54%$14.43$13.82509,231 shs$1.07 billion03/05/2025$14.26$14.27+0.07%$14.52$13.85714,888 shs$1.08 billion03/04/2025$14.19$14.26+0.49%$14.58$13.54690,573 shs$1.08 billion03/03/2025$15.45$14.19-8.16%$15.51$13.861.29 million shs$1.08 billion02/28/2025$15.00$15.45+3.00%$15.46$14.391.11 million shs$1.17 billion02/27/2025$17.06$15.00-12.08%$17.29$14.991.05 million shs$1.14 billion Related Companies RNA Stock Price Chart ACLX Stock Price Chart OGN Stock Price Chart ZLAB Stock Price Chart RARE Stock Price Chart SWTX Stock Price Chart AKRO Stock Price Chart ALVO Stock Price Chart RYTM Stock Price Chart MRUS Stock Price Chart Receive NRIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRIX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredRevealed: The Chip Stock Redefining AI as We Know ItIn this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech fir...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
